Compare Avail (AVAIL) vs Injective (INJ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Avail vs Injective — how do they compare? Avail trades at Rp51.1 (market cap Rp200,88M, Rp8,7M 24h volume), while Injective trades at Rp83,895 (market cap Rp8,37T, Rp1,26T 24h volume). The key difference: Injective is far larger — about 41666.7× Avail's market cap, and Avail's circulating supply is 3,9B AVAIL versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Avail for 18 Days and Injective for 36 Days on average.
| AVAIL | INJ | |
|---|---|---|
Market Cap | Rp200,88M | Rp8,37T |
Volume (24h) | Rp8,7M | Rp1,26T |
Circulating Supply | 3,9B AVAIL | 100M INJ |
Typical Hold Time | 18 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Avail is trading at Rp52.169 with a market cap of Rp203.92M, showing a bearish technical signal driven by moving averages. The asset has a short hold time of 18 days, indicating trader impatience. No major protocol updates or ecosystem developments are noted recently. Support is firm at Rp51 and Rp52, while resistance lies at Rp52 and Rp53, creating a tight trading range.
Overall outlook is cautious due to bearish momentum and low liquidity. Key opportunities include potential rebounds from support levels, but risks involve high volatility and limited market depth. Investors should monitor for any network updates or exchange listings that could improve sentiment.
INJ is trading at Rp83,360 with a market cap of Rp8.39T, showing neutral technical signals overall. The asset is currently positioned between key support at Rp82,799 and resistance at Rp86,949, with mixed moving average signals but neutral oscillators. Recent network activity shows an average hold time of 36 days, indicating moderate holding behavior among investors.
Outlook remains cautiously neutral with potential for movement toward resistance levels. Key opportunities include protocol ecosystem growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor volume patterns and network adoption metrics for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Avail
Avail is a blockchain project designed to address the complexities of data availability and interoperability within the decentralized ecosystem. As a modular blockchain base layer, Avail provides a common data availability layer that facilitates seamless interaction between different blockchains. This foundational layer is crucial for next-generation, trust-minimized applications, enabling them to operate efficiently and securely.
Read more on AVAIL →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
